Alx Oncology Holdings Inc. · NASDAQ:ALXO
Lettmann Jason sold 2,230 Alx Oncology Holdings Inc. shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 18, 2026
On Aug 17, 2026, Lettmann Jason (Director, CHIEF EXECUTIVE OFFICER) sold 2,230 Alx Oncology Holdings Inc. shares at US$1.93 for US$4,304, leaving 294,379 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 2,230 shares
- Price
- US$1.93
- Value
- US$4,304
- Holding after
- 294,379 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Sale | 2,230 | US$1.93 | 294,379 | Direct |
Source
Related
- Alx Oncology Holdings Inc.
- Lettmann Jason
- Alx Oncology Holdings Inc. shareholders
- Schedule 13D/A · venBio Global Strategic Fund, L.P. · Oct 16, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Wong Shelly · Jul 6, 2026